Zdrowie i gospodarka · 08/06/2010
FDA to Issue Notice on Prescription Drug User Fee Act Reauthorization Meetings and Stakeholder Participation
The Food and Drug Administration (FDA) is issuing a notice regarding meetings on the reauthorization of the Prescription Drug User Fee Act and a request for stakeholders to notify their intention to participate
Source: Federal Register — Health and Human ServicesOpen original release →